INTERCEPT PHARMACEUTICALS, INC.·4

Jan 3, 7:00 PM ET

Kim Richard J 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2019-12-31
Kim Richard J
SVP, Commercial US
Transactions
  • Tax Payment

    Common Stock

    2019-12-31$123.92/sh340$42,13316,407 total
  • Tax Payment

    Common Stock

    2020-01-01$123.92/sh309$38,29116,098 total
Footnotes (2)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.
  • [F2]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock and restricted stock unit awards previously granted to the reporting person.

Documents

1 file
  • 4
    tm201209d9_4.xmlPrimary

    OWNERSHIP DOCUMENT